Privia Health Revenue 2020-2023 | PRVA

Privia Health revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Privia Health Annual Revenue
(Millions of US $)
2023 $1,658
2022 $1,357
2021 $966
2020 $817
2019 $786
Privia Health Quarterly Revenue
(Millions of US $)
2023-12-31 $441
2023-09-30 $417
2023-06-30 $413
2023-03-31 $386
2022-12-31 $364
2022-09-30 $343
2022-06-30 $336
2022-03-31 $314
2021-12-31 $275
2021-09-30 $252
2021-06-30 $226
2021-03-31 $214
2020-12-31 $214
2020-09-30 $207
2020-06-30 $183
2020-03-31 $213
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.135B $1.658B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.221B 21.82
Inspire Medical Systems (INSP) United States $6.999B 0.00
IRhythm Technologies (IRTC) United States $3.463B 0.00
Axonics (AXNX) United States $3.394B 0.00
10x Genomics (TXG) United States $3.206B 0.00
Enovis (ENOV) United States $3.022B 22.96
Azenta (AZTA) United States $2.872B 234.09
Olink Holding AB (publ) (OLK) Sweden $2.869B 0.00
Hims & Hers Health (HIMS) United States $2.629B 0.00
Schrodinger (SDGR) United States $1.688B 0.00
Omnicell (OMCL) United States $1.246B 30.48
Phreesia (PHR) United States $1.154B 0.00
Definitive Healthcare (DH) United States $0.793B 0.00
Standard BioTools (LAB) United States $0.685B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Talkspace (TALK) United States $0.520B 0.00
Clover Health Investments (CLOV) United States $0.332B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.323B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
American Well (AMWL) United States $0.156B 0.00
P3 Health Partners (PIII) United States $0.152B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.136B 0.00
MSP Recovery (LIFW) United States $0.131B 0.00
Outset Medical (OM) United States $0.123B 0.00
TruBridge (TBRG) United States $0.115B 4.91
111 (YI) China $0.084B 0.00
SHL Telemedicine (SHLT) Israel $0.077B 0.00
Future Health ESG (FHLT) United States $0.070B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.045B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00